Bowers added that to increase access to the latest drugs, the "cancer system" must be organized in such a way as to ...

Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.

RenovaroCube (Cube, the Company), a leading AI-driven innovator using multi-omics technology for cancer profiling, is pleased ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalized medicine, a raft of new ...

Breastfeeding is feasible for patients with hormone receptor–positive breast cancer who are undergoing a break of endocrine ...

Before the annual congress of the European Society for Medical Oncology began in Barcelona, clinicians held a press ...

High response rates reported by GSK and iTeos at the 2024 European Society for Medical Oncology Congress offer a ray of light ...

SOLARIS (Alliance A021703), a multicenter, double-blind, randomized Phase III clinical trial led by Dana-Farber Cancer ...

Metastatic solid tumors may be curable now. Among the most profound results presented over the weekend at the European ...